VIDEO: PFO closure effectiveness to be tested in real-world population
LAS VEGAS — In this video exclusive, Ignacio Inglessis, MD, medical director of the structural heart disease program at the Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses the ideas behind the REDUCE postapproval study of patent foramen ovale closure with the Gore Cardioform device (W.L. Gore and Associates) as a strategy for secondary stroke prevention.
Unlike other studies of PFO closure for stroke prevention, patients in this study will have their heart rhythm monitored to distinguish those who had a stroke because of atrial fibrillation from those whose stroke might be PFO-related, said Inglessis, who co-chaired a lunch symposium on PFO closure at the Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Watch the video for more.